Julia Tjandera
Family · Tallahassee, FLNPI 1568056828
Payments from drug & device makers
Across 267 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$658
- Pfizer$626
- Collegium Pharmaceutical, Inc.$600
- UCB, Inc.$391
- Lundbeck LLC$299
- CSL Behring$254
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,90599%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $658 |
| Pfizer | 33 | $626 |
| Collegium Pharmaceutical, Inc. | 40 | $600 |
| UCB, Inc. | 21 | $391 |
| Lundbeck LLC | 12 | $299 |
| CSL Behring | 13 | $254 |
| Eisai Inc. | 12 | $229 |
| AstraZeneca | 10 | $228 |
| Teva Pharmaceuticals USA, Inc. | 11 | $219 |
| Amgen | 9 | $212 |
| Neurelis, Inc. | 10 | $207 |
| Acadia Pharmaceuticals Inc | 6 | $110 |
| Lilly USA, LLC | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| SK Life Science, Inc. | 5 | $84 |
| Neurocrine Biosciences, Inc. | 3 | $74 |
| Grifols USA, LLC | 4 | $71 |
| Scilex Pharmaceuticals Inc. | 4 | $67 |
| Nevro Corp. | 3 | $61 |
| Globus Medical | 3 | $53 |
| Merz Pharmaceuticals, LLC | 1 | $39 |
| Averitas Pharma Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $26 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Sanofi | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Vertex | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$4,938 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 31 | $630,879 |
| ValtocoDiazepam | 41 | $60,358 |
| GlatopaGlatiramer Acetate | 29 | $40,614 |
| QuliptaAtogepant | 31 | $32,075 |
| Nurtec OdtRimegepant Sulfate | 17 | $27,015 |
| UbrelvyUbrogepant | 14 | $21,416 |
| Aimovig AutoinjectorErenumab-Aooe | 22 | $18,056 |
| Emgality PenGalcanezumab-Gnlm | 23 | $17,087 |
| Dimethyl Fumarate | 13 | $11,493 |
| Pregabalin | 325 | $8,230 |
| MovantikNaloxegol Oxalate | 12 | $7,469 |
| Gabapentin | 343 | $5,844 |
| Celecoxib | 95 | $3,452 |
| Tramadol Hcl | 287 | $3,114 |
| Tizanidine Hcl | 234 | $2,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $35 | $630,87931 claims |
| Neurelis, Inc.Valtoco | $207 | $60,35841 claims |
| AbbVieQulipta, Ubrelvy | $658 | $53,49145 claims |
| PfizerNurtec Odt | $626 | $27,01517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Tallahassee
- Kathleen WilsonTallahassee$154K
- Brittany YatesTallahassee$73K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.